Life Science Research Professional
Biochemistry · India · 2023-02-06
Proposed Endeavor
The petitioner proposes to continue her research on investigating different aspects of intestinal innate immunity to identify novel targets and therapies for inflammatory bowel diseases, including Ulcerative Colitis and Crohn’s disease. Her work specifically focuses on the role of the gut microbiome in obesity and inflammasome activation in pulmonary fibrosis.
Framework Evaluation
3 of 3 criteria metThe endeavor addresses inflammatory bowel diseases affecting 1.6 million Americans and aligns with national health interests for the elderly.
The petitioner has 4 years of direct research experience, 10 publications, and 253 citations demonstrating her influence in the field.
The urgency of treating obesity and inflammatory conditions, supported by federal funding, makes the waiver beneficial to the U.S.
Why This Petition Was Approved
Evidence
Similar Cases
Research Scientist
Biotechnology · China
Clinical Research Coordinator
Biotechnology · Pakistan
Postdoctoral Researcher
Biotechnology · Turkey
Postdoctoral Researcher
Biotechnology · Pakistan
Frequently Asked Questions
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-02-06.
Browse all casesAt a Glance
EB-2 (NIW) Case Data
Scraped Case Data
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist